RECRUITING

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Talk to us

Conditions

Shock Hemodynamic Monitoring Stroke Volume Measurement Passive Leg Raising Critical IllnessCheeta NICOMBioreactanceTransthoracic EchocardiographyPassive Leg RaisingStroke VolumeShock AssssmentNoninvasive Cardiac Output Monitoring

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

Official Title

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Quick Facts

Study Start:2024-10-19
Study Completion:2026-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07020637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients aged 18 years or older Clinical diagnosis of shock as determined by the treating ICU physician (e.g., hypotension requiring vasopressors or evidence of end-organ hypoperfusion) Able to obtain informed consent from the patient or a legally authorized representative Enrollment within 24 hours of ICU admission
  1. * Pregnancy Known severe aortic valve disease or dynamic left ventricular outflow tract obstruction Morbid obesity (BMI \> 40) that precludes accurate echocardiographic imaging Presence of cardiac arrhythmias (e.g., atrial fibrillation with rapid ventricular response) affecting stroke volume measurements Implanted cardiac assist devices (e.g., LVAD, pacemaker dependency) Imminent death or decision for comfort care only

Contacts and Locations

Study Contact

Mutsumi J Kioka, Medical Doctor
CONTACT
7026712345
mutsumi.kioka@unlv.edu
Office of Research Integrity Human Subjects UNLV
CONTACT
7028952794
IRB@unlv.edu

Principal Investigator

Mutsumi J Kioka, Medical Doctor
PRINCIPAL_INVESTIGATOR
UNLV

Study Locations (Sites)

University Medical Center Southern Nevada
Las Vegas, Nevada, 89102
United States

Collaborators and Investigators

Sponsor: University of Nevada, Las Vegas

  • Mutsumi J Kioka, Medical Doctor, PRINCIPAL_INVESTIGATOR, UNLV

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-19
Study Completion Date2026-09-01

Study Record Updates

Study Start Date2024-10-19
Study Completion Date2026-09-01

Terms related to this study

Keywords Provided by Researchers

  • Cheeta NICOM
  • Bioreactance
  • Transthoracic Echocardiography
  • Passive Leg Raising
  • Stroke Volume
  • Shock Assssment
  • Noninvasive Cardiac Output Monitoring

Additional Relevant MeSH Terms

  • Shock Hemodynamic Monitoring Stroke Volume Measurement Passive Leg Raising Critical Illness